Search

everythinglearnresearchcommunity

for

Search:↓

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Early treatment of PCOS is crucial for better health and quality of life.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Different growth patterns in thyroid tumors are influenced by where cell growth and death occur.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Differentiating PCOS from NCAH helps improve diagnosis and treatment.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Finasteride negatively affects fish reproduction and gonadal development.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.